Also trades as: NEULANDLAB.BO (BSE) · $vol 1M
NEULANDLAB.NS NSE
Neuland Laboratories Limited
1W: -0.8%
1M: +10.9%
3M: +26.7%
YTD: +22.6%
1Y: +43.1%
3Y: +888.6%
5Y: +723.8%
₹16,689.00 ($174.43)
-1.00 (-0.01%)
Weekly Expected Move ±6.2%
₹14612
₹15641
₹16670
₹17699
₹18728
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹214.2B ($2.2B)
52W Range11011-19747
Volume64,307
Avg Volume58,378
Beta-0.32
Dividend₹12.00
Analyst Ratings
No analyst coverage
Company Info
CEODavuluri Saharsh Rao
Employees1,643
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2008-10-13
Websiteneulandlabs.com
Phoenix IVY Building
Hyderabad 500033
IN
Hyderabad 500033
IN
91 40 6761 1600
About Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found